Pharmacological interventions targeting β-adrenoceptors in colorectal cancer: an evolving paradigm.

Inflammopharmacology · 2025 · PMC12552305 · PMID 40952582

Europe PMC DOI

hedged sentence

0.1510

closest p · 3.0× alpha

0.1510

boldest claim

The sentences

did not reach statistical significancep = 0.151not close (p > 0.1)

Mortality was also lower in the treatment group (0/11, 0%) versus the placebo group (3/17, 17.6%), though this difference did not reach statistical significance (p = 0.151) (Ricon-Becker et al. 2023 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.